Back to Search Start Over

Synergistic antitumor activity of the combination of the multi-targetes tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3666..3b932db90dbae4c8557d6dd20783def2